Mycotoxins as human carcinogens—the IARC Monographs classification

Mycotoxin Research

Volumn 33, Issue 1, 2017, Pages 65-73

  Ostry, Vladimir ^a   Malir, Frantisek ^b   Toman, Jakub ^b   Grosse, Yann ^c  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Aflatoxins; Carcinogenicity; Fumonisins; IARC; Mycotoxins; Ochratoxin A

Indexed keywords

AFLATOXIN B1; AFLATOXIN B2; AFLATOXIN G1; AFLATOXIN G2; AFLATOXIN M1; CARCINOGEN; CITRININ; FUMONISIN; FUMONISIN B1; FUMONISIN B2; FUSARENON X; KOJIC ACID; LUTEOSKYRIN; MYCOTOXIN; NIVALENOL; OCHRATOXIN; PATULIN; PENICILLIC ACID; STERIGMATOCYSTIN; T 2 TOXIN; VOMITOXIN; ZEARALENONE; AFLATOXIN; MUTAGENIC AGENT;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; FOOD CONTAMINATION; FOOD INTAKE; GENOTOXICITY; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; NONHUMAN; OXIDATIVE STRESS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; FRANCE; METABOLISM; NEOPLASMS;

AFLATOXINS; ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; FRANCE; FUMONISINS; HUMANS; MUTAGENS; NEOPLASMS; OCHRATOXINS;

EID: 84997208407     PISSN: 01787888     EISSN: 18671632     Source Type: Journal    
DOI: 10.1007/s12550-016-0265-7     Document Type: Article

References (95)

1. Akman S, Adams M, Case D, Park G, Manderville R (2012) Mutagenicity of ochratoxin A and its hydroquinone metabolite in the SupF gene of the mutation reporter plasmid ps189. Toxins 4:267–280. doi:10.3390/toxins4040267
2. Ali R, Mittelstaedt R, Shaddock J, Ding W, Bhalli J, Khan Q, Heflich R (2011) Comparative analysis of micronuclei and DNA damage induced by ochratoxin A in two mammalian cell lines. Mutat Res 723:58–64. doi:10.1016/j.mrgentox.2011.04.002
3. Arbillaga L, Azqueta A, Ezpeleta O, de Cerain AL (2007) Oxidative DNA damage induced by ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Mutagenesis 22:35–42. doi:10.1093/mutage/gel049
4. Arlt VM, Pfohl-Leszkowicz A, Cosyns JP, Schmeiser HH (2001) Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 494:143–150. doi:10.1016/S1383-5718(01)00188-7
5. Azémar B, Pinelli E, Escourrou G, Plante P, Pfohl-Leszkowicz AP (1997) Evidence that DNA adducts in some human kidney tumours in France are related to ochratoxin A. Mutat Res 379:157
6. Bennett JW, Klich M (2003) Mycotoxins. Clin Microbiol Rev 16:497–516
7. Blount WP (1961) Turkey “X” disease. J Br Turkey Fed 9:55–58
8. Boonen J, Malysheva SV, Taevernier L, Diana Di Mavungu J, De Saeger S, De Spiegeleer B (2012) Human skin penetration of selected model mycotoxins. Toxicology 301:21–32. doi:10.1016/j.tox.2012.06.012
9. Brown A, Odell E, Mantle P (2007) DNA ploidy distribution in renal tumours induced in male rats by dietary Ochratoxin A. Exp Toxicol Pathol 59:85–95. doi:10.1016/j.etp.2007.05.001
10. Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce C (2002) Nonlinear partial differential equations and applications: frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99:15524–15529. doi:10.1073/pnas.242606799
11. Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce C (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 101:2999–3004. doi:10.1073/pnas.0307323101
12. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Esteve J, Steinmann J, Tillmann T, Michelon J, Bartsch H (1999) Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. IARC 639. doi:10.1097/00005392-199908000-00132
13. Cavin C, Delatour T, Kuan MM, Fenaille F, Holzhauser D, Guignard G, Bezencon C, Piguet D, Parisod V, Richoz-Payot J, Schilter B (2009) Ochratoxin A-mediated DNA and protein damage: roles of nitrosative and oxidative stresses. Toxicol Sci 110:84–94. doi:10.1093/toxsci/kfp090
14. Degen GH (2011) Tools for investigating workplace-related risks from mycotoxin exposure. World Mycotoxin J 4:315–327. doi:10.3920/WMJ2011.1295
15. Delatour T, Mally A, Richoz J, Özden S, Dekant W, Ihmels H, Otto D, Gasparutto D, Marin-Kuan M, Schilter B, Cavin C (2008) Absence of 21-deoxyguanosine-carbon 8-bound Ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol Nutr Food Res 52:472–482. doi:10.1002/mnfr.200700276
16. Di Paolo N, Guarnieri A, Loi F, Sacchi G, Mangiarotti AM, Di Paolo M (1993) Acute renal failure from inhalation of mycotoxins. Nephron 64:621–625
17. Dvorackova I (1976) Aflatoxin inhalation and alveolar cell carcinoma. Br Med J 1(6011):691–691
18. 1 in lung tissue. J Tox Environ Health 1986(18):153–157
19. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville R (2004) Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 17:1289–1296. doi:10.1021/tx049877s
20. Gautier J, Holzhaeuser D, Markovic J, Gremaud E, Schilter B, Turesky R (2001) Oxidative damage and stress response from ochratoxin a exposure in rats. Free Radic Biol Med 30:1089–1098. doi:10.1016/s0891-5849(01)00507-x
21. González-Arias C, Benitez-Trinidad A, Sordo M, Robledo-Marenco L, Medina-Díaz I, Barrón-Vivanco B, Marín S, Sanchis V, Ramos A, Rojas-García A (2014) Low doses of ochratoxin A induce micronucleus formation and delay DNA repair in human lymphocytes. Food Chem Toxicol 74:249–254. doi:10.1016/j.fct.2014.10.006
22. Gross-Steinmeyer K, Weymann J, Hege H, Metzler M (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J Agric Food Chem 50:938–945. doi:10.1021/jf0111817
23. Hadjeba-Medjdoub K, Tozlovanu M, Pfohl-Leszkowicz A, Frenette C, Paugh R, Manderville R (2012) Structure–activity relationships imply different mechanisms of action for Ochratoxin A-mediated cytotoxicity and genotoxicity. Chem Res Toxicol 25:181–190. doi:10.1021/tx200406c
24. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70. doi:10.1016/S0092-8674(00)81683-9
25. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. doi:10.1016/j.cell.2011.02.013
26. Hennemeier I, Humpf HU, Gekle M, Schwerdt G (2014) Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cells. Toxicol 324:116–122. doi:10.1016/j.tox.2014.07.012
27. Heussner AH, Bingle LEH (2015) Comparative ochratoxin toxicity: a review of the available data. Toxins 7:4253–4282. doi:10.3390/toxins7104253
28. Hibi D, Suzuki Y, Ishii Y, Jin M, Watanabe M, Sugita-Konishi Y, Yanai T, Nohmi T, Nishikawa A, Umemura T (2011) Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol Sci 122:406–414. doi:10.1093/toxsci/kfr139
29. IARC (1976) Monographs on the evaluation of carcinogenic risks of chemicals to man: some naturally occurring substances. Lyon, France: International Agency for Research on Cancer 10:191–197
30. IARC (1983) Monographs on the evaluation of carcinogenic risks of chemicals to humans: some food additives, feed additives and naturally occurring substances. Lyon, France: International Agency for Research on Cancer 31:191–206
31. IARC (1987) Monographs on the evaluation of carcinogenic risks to humans: Overall evaluations of carcinogenicity: An updating of IARC Monographs. Lyon, France: International Agency for Research on Cancer 1–403
32. IARC (1993) Monographs on the evaluation of carcinogenic risks to humans: some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: International Agency for Research on Cancer 56:1–599
33. IARC (2001) Some thyrotropic agents. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer 79:607–618
34. IARC (2002) Traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer 82:1–556
35. IARC (2012) Monographs on the evaluation of carcinogenic risks to humans: chemical agents and related occupations. A review of human carcinogens. Lyon, France: International Agency for Research on Cancer 100F:224–248
36. IARC (2015) Preamble to the IARC Monographs (amended January 2006). Available online: http://monographs.iarc.fr/ENG/Preamble/. Accessed 25 October 2016
37. IARC (2016a) Presentations related to the IARC Monographs. IARC Monographs, Evaluations. IARC, Lyon. Available online: http://monographs.iarc.fr/ENG/Publications/Evaluations.pdf. Accessed 25 October 2016
38. IARC (2016b) Agents classified by the IARC Monographs, Volumes 1–116. Available online: http://monographs.iarc.fr/ENG/Classification/. Accessed 25 October 2016
39. Jennings-Gee J, Tozlovanu M, Manderville R, Miller M, Pfohl-Leszkowicz A, Schwartz G (2010) Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins 2:1428–1444. doi:10.3390/toxins2061428
40. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P (1996) Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 68(4):207–218
41. Kelman BJ, Robbins CA, Swenson LJ, Hardin BD (2004) Risk from inhaled mycotoxins in indoor office and residential environments. Int J Toxicol 23:3–10. doi:10.1080/10915810490265423
42. Kensler TW, Roebuck BD, Wogan GN, Groopman JD (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 120:S28–S48. doi:10.1093/toxsci/kfq283
43. Lancaster MC, Jenkins FP, Philip JM (1961) Toxicity associated with certain samples of groundnuts. Nature 192:1095–1096
44. Loeb LA, Harris CC (2008) Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res 68:6863–6872. doi:10.1158/0008-5472.CAN-08-2852
45. Lock E, Hard G (2004) Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit Rev Toxicol 34:211–299. doi:10.1080/10408440490265210
46. Luch A (2005) Nature and nurture—lessons from chemical carcinogenesis. Nat Rev Cancer 5:113–125. doi:10.1038/nrc1546
47. Malir F, Ostry V, Grosse Y, Roubal T, Skarkova J, Ruprich J (2006) Monitoring the mycotoxins in food and their biomarkers in the Czech Republic. Mol Nutr Food Res 50:513–518. doi:10.1002/mnfr.200500175
48. Malir F, Ostry V, Pfohl-Leszkowicz A, Malir J, Toman J (2016) Ochratoxin A: 50 years of research. Toxins 8:1–49. doi:10.3390/toxins8070191
49. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Völkel W, Dekant W (2004) Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 17:234–242. doi:10.1021/tx034188m
50. Mally A, Pepe G, Ravoori S, Fiore M, Gupta R, Dekant W, Mosesso P (2005) Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem Res Toxicol 18:1253–1261. doi:10.1021/tx049650x
51. Mally A, Dekant W (2009) Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467–478. doi:10.1002/mnfr.200800149
52. Mally A (2012) Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Toxicol Sci 127:315–330. doi:10.1093/toxsci/kfs105
53. Manderville RA (2005) A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 18:1091–1097. doi:10.1021/tx050070p
54. Manderville R, Pfohl-Leszkowicz A (2008) Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotoxin J 1:357–367. doi:10.3920/WMJ2008.x039
55. Mantle P, Kulinskaya E, Nestler S (2005) Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam 22:58–64. doi:10.1080/02652030500358431
56. Mantle P, Faucet-Marquis V, Manderville R, Squillaci B, Pfohl-Leszkowicz A (2010) Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:9–98. doi:10.1021/tx900295a
57. Mantle P, Kulinskaya E (2010) Lifetime, low-dose Ochratoxin A dietary study on renal carcinogenesis in male Fischer rats. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:1566–1573. doi:10.1080/19440049.2010.502302
58. Maaroufi K, Pfohl-Leszkowicz A, Achour A, El May M, Grosse Y, Hammami M, Ellouz F, Creppy EE, Bacha H (1994) Genotoxicity of ochratoxin A, relation to renal tumors. Arch Inst Pasteur Tunis 71:21–31
59. Marin-Kuan M, Ehrlich V, Delatour T, Cavin C, Schilter B (2011) Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin A. J Toxicol 2011:1–15. doi:10.1155/2011/645361
60. Molinié A, Pfohl-Leszkowicz A (2003) Toxic effects of co-contamination of ochratoxin A and citrinin. Drug Metab Rev 35(Suppl. 1):77
61. Newberne PM (1974) Mycotoxins: toxicity, carcinogenicity, and the influence of various nutritional conditions. Environ Health Perspect 9:1–32
62. Obrecht-Pflumio S, Dirheimer G (2000) In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem Biol Interact 127:29–44. doi:10.1016/s0009-2797(00)00169-1
63. Obrecht-Pflumio S, Dirheimer G (2001) Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in the presence of ochratoxin A. Arch Toxicol 75:583–590. doi:10.1007/s00204-001-0289-3
64. Palma N, Cinelli S, Sapora O, Wilson S, Dogliotti E (2007) Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem Res Toxicol 20:1031–1037. doi:10.1021/tx700027j
65. Peers FG, Gilman GA, Linsell CA (1976) Dietary aflatoxins and human liver cancer: a study in Swaziland. Int J Cancer 7:167–176
66. Petkova-Bocharova T, Stoichev I, Chernozemsky I, Castegnaro M, Pfohl-Leszkowicz A (1998) Formation of DNA adducts in tissues of mouse progeny through transplacental contamination and/or lactation after administration of a single dose of ochratoxin A to the pregnant mother. Environ Mol Mutagen 32:155–162. doi:10.1002/(sici)1098-2280(1998)32:2<155::aid-em11>3.0.co;2-o
67. Petkova-Bocharova T, El Adlouni C, Faucet V, Pfohl-Leszkowicz A, Mantle P (2003) Analysis for DNA adducts, ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis. Facta Univ Ser Med Biol 10:111–115
68. Pfohl-Leszkowicz A, Grosse Y, Kane A, Gharbi Y, Baudrimont I, Obrecht S, Creppy EE, Dirheimer G (1993a) Is the oxidative pathway implicated in the genotoxicity of ochratoxin A? In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and related pathologies, vol 231. Colloque INSERM/John Libbey Eurotext Ltd., London, pp. 177–187
69. Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy E, Dirheimer G (1993b) Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin Ochratoxin A. Mutat Res 289:265–273
70. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Petkova-Bocharova T (1993c) In: Phillips DH, Castegnaro M, Bartsch H (eds) Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects, vol 124. IARC Sci. Publ, Lyon, France, pp. 115–122
71. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M (1998) Sex and strain differences in Ochratoxin A metabolism and DNA adduction in two strains of rats. Mol Carcinog 23:76–83
72. Pfohl-Leszkowicz A, Bartsch H, Azemar B, Mohr U, Esteve J, Castegnaro M (2002) MESNA protects rats against nephro-toxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Univ Ser Med Bio 9:57–63
73. Pfohl-Leszkowicz A, Castegnaro M (2005) Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam 22:75–87. doi:10.1080/02652030500309400
74. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V (2007) New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:1131–1146. doi:10.1002/mnfr.200700045
75. Pfohl-Leszkowicz A, Molinié A, Tozlovanu M, Manderville RA (2008) Combined toxic effects of ochratoxin A and citrinin, in vitro and in vivo. In Food Contaminats Mycotoxins & Food Allergen; Siantar, DP, Trucksess MW, Scott PM, Herman EM, Eds.; Publisher: ACS Symposium series: Washington, DC, USA; Volume 1001, pp. 56–80.
76. Pfohl-Leszkowicz A, Gabryelski W, Manderville R (2009) Formation of 2′-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA. Mol Nutr Food Res 53:154–155. doi:10.1002/mnfr.200890049
77. Pfohl-Leszkowicz A (2009) Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arch Ind Hyg Toxicol 60:465–483. doi:10.2478/10004-1254-60-2009-2000
78. Pfohl-Leszkowicz A, Manderville R (2012) An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem Res Toxicol 25:252–262. doi:10.1021/tx200430f
79. Qi X, Yu T, Zhu L, Gao J, He X, Huang K, Luo Y, Xu W (2014) Ochratoxin A induces rat renal carcinogenicity with limited induction of oxidative stress responses. Toxicol Appl Pharmacol 280:543–549. doi:10.1016/j.taap.2014.08.030
80. Richard JL (2007) Some major mycotoxins and their mycotoxicoses—an overview. Int J Food Microbiol 119:3–10. doi:10.1016/j.ijfoodmicro.2007.07.019
81. Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ (2000) Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg 15:773–784. doi:10.1080/10473220050129419
82. Sargeant K, Sheridan A, O’Kelly J, Carnaghan RBA (1961) Toxicity associated with certain samples of groundnuts. Nature 192:1096–1097
83. Schwartz GG (2002) Hypothesis: Does OTA cause testicular cancer. Cancer Causes Control 13:91–100. doi:10.1023/A:1013973715289
84. Schwartz G, Faucet-Marquis V, Jennings-Gee J, Miller M, Manderville R, Pfohl-Leszkowicz A (2007) Prenatal exposure to ochratoxin A causes DNA adducts in the testes of newborn mice. Scand J Urol Nephrol Suppl 1:217–220
85. Schwartz G, Manderville R, Pfohl-Leszkowicz A (2010) Response to comments of Peter G. Mantle Toxins 2:2337–2339. doi:10.3390/toxins2102337
86. Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, Loboda A (2013) Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res 57:504–515. doi:10.1002/mnfr.201200456
87. Stark AA (1980) Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action. Ann Rev Microbiol 34:235–262
88. Stoev S (2010) Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins 2:649–664. doi:10.3390/toxins2040649
89. Van Rensburg SJ, Cook–Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF (1985) Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51:713–726
90. Van Rensburg SJ, Van Schalkwyk GC, Van Schalkwyk DJ (1990) Primary liver cancer and aflatoxin intake in Transkei. J Environ Pathol Toxicol Oncol 10:11–16
91. Wild CP, Gong YY (2010) Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 31:71–82. doi:10.1093/carcin/bgp264
92. 1 carcinogenesis in the rat. Cancer Res 27:2370–2376
93. Wogan GN (1973) Aflatoxin carcinogenesis. In: Busch H (ed) Methods in cancer research. Academic Press, New York, pp. 309–344
94. Wu TS, Yang JJ, Wang YW, Yu FY, Liu BH (2016) Mycotoxin ochratoxin a disrupts renal development via a miR-731/prolactin receptor axis in zebrafish. Toxicol Res 5(2):519–529. doi:10.1039/C5TX00360A
95. Zeljezic D, Domijan A, Peraica M (2006) DNA damage by Ochratoxin A in rat kidney assessed by the alkaline comet assay. Braz J Med Biol Res 39:1563–1568. doi:10.1590/S0100-879X2006005000029